AI can help predict Skin Cancer Recurrence

 

Hello! Today we have an entry in the field of medicine.

What is skin cancer recurrence?

An early-stage skin cancer type called melanoma is treatable if diagnosed early enough. Most melanoma deaths in the US occur because of recurrence of the disease which was early stage at the time of diagnosis. However, recurrence is not detected until the cancer starts to spread; called symptomatic metastatic progression. This is where prognostic tools can be helpful for regular surveillance and quick action to stave off mortality and ensure health. Also, identifying high-risk patients can help in determining who should receive special therapies and treatments.

Enter Machine Learning.

A team led by investigators at Massachusetts General Hospital performed two types Machine Learning prediction with nine different models:

  1. Melanoma Recurrence Classification: Where the prediction would be a probability that melanoma recurrence would occur.
  2. Time-To-Event Melanoma Recurrence Risk Prediction: Where the prediction would be time taken for the event of melanoma recurrence to definitely occur.

The data sets used for the training and validation were the MGB cohort and the DFCI cohort. MGB is the Mass General Brigham healthcare system and DFCI is the Dana-Farber Cancer Institute.

A comprehensive array of over 36 demographic, clinical, and histopathologic features were used to build the model.

The machine learning models were validated internally and externally. Stratified five-fold cross-validation was done on the model trained using the MGB cohort for internal validation. For external validation, the model trained on the MGB cohort was validated on the DFCI cohort.

Model performance for the recurrence classification was AUC: 0.812. Model performance for the time-to-event recurrence prediction was time-dependent AUC: 0.820.

The predictive capabilities of these models can be improved by incorporating additional features such as digital histopathology images, genomics data, and novel tumor biomarkers. Nevertheless, the researchers opine that these current models can be deployed clinically for detection of high-risk patients who may benefit from early interventions.

This research advancement can be found in full here.

Key Terms:

  1. Melanoma
  2. Histopathologic
  3. Stratified five-fold cross-validation
  4. AUC: Area Under Curve
  5. Time-Dependent AUC


Comments

Popular posts from this blog

Introduction

Crater Detection

AI Helps find Earth-like Habitable Exo-planets

Contact Me!

Name

Email *

Message *

Search Wikipedia For Anything!

Search results